Covid-19 and the South African pharmaceutical supply chain

Abstract

This research aimed to identify the key drivers of the pharmaceutical supply chain during the COVID-19 pandemic disruption, focusing on the South African pharmaceutical industry. The study aimed to unveil the dynamic strategies and challenges experienced during the pandemic and suggest recommendations for resilient supply chain operations. The study drew on established supply chain management theories and integrated them with the unique and novel circumstances of the COVID-19 pandemic. It mainly referred to theories regarding pricing, strategic sourcing, ICT usage, product availability, and logistics management contextualised within the pharmaceutical industry. An exploratory research approach was adopted to uncover the five overarching themes that function as pharmaceutical supply chain drivers during the COVID-19 pandemic. Semi-structured interviews were used to acquire the primary data with industry supply chain professionals, supplemented with secondary data from industry reports and relevant literature. The findings revealed that the pricing of medications, strategic sourcing decisions, information and communication technology, the availability of pharmaceutical products, and logistics management played critical roles in the pharmaceutical industry's supply chain during the COVID-19 pandemic. Disruptions caused by the COVID-19 pandemic led to challenges such as price hikes, supply shortages, and logistical complications. The study provides crucial insights into managing supply chain disruptions amid a global health crisis. Implementing dynamic pricing mechanisms, developing resilient sourcing strategies, using ICT effectively, improving inventory management, and enhancing logistics management are recommended for robust supply chain operations. The findings contribute to academia by enriching the existing body of knowledge and offering practical solutions for industry supply chain professionals. The research is original and timely, offering a unique perspective on the South African pharmaceutical industry's supply chain during an unprecedented global health crisis. The results are valuable for academia and industry, shedding light on the adaptive strategies, challenges encountered, and lessons learned from navigating the pharmaceutical supply chain during the COVID-19 pandemic.

Keywords: {'name': 'Supply chain drivers'}, {'name': 'pharmaceutical industry'}, {'name': 'COVID-19 pandemic'}, {'name': 'Supply Chain Risk Management'}, {'name': 'Pricing'}, {'name': 'Sourcing'}, {'name': 'Strategies'}

Authors & affiliations

Blessing Takawira
Affiliation not supplied

David Pooe
Affiliation not supplied

Deposited references

Supplied references, not a list of publications citing this article.

DOI: 10.1016/j.ibusrev.2021.101967

DOI: 10.1007/s11133-019-9413-7

DOI: 10.1007/s40199-020-00358-5

DOI: 10.1016/j.ifacol.2022.10.035

DOI: 10.3389/fpubh.2022.928065

DOI: 10.53841/bpsqmip.2022.1.33.46

Chopra, S. (2020). Supply chain management : strategy, planning and operation (13th edition, Seventh Global Edition. ed.). Pearson Education.

DOI: 10.46254/SA02.20210580

Christopher, M. (2022). Logistics and Supply Chain Management (6th ed.). Pearson Education, Limited. https://public.ebookcentral.proquest.com/choice/PublicFullRecord.aspx?p=7150142

DOI: 10.1111/deci.12468

Creswell, J. W., & Creswell, J. D. (2023). Research design : qualitative, quantitative, and mixed methods approaches (Sixth edition. ed.). SAGE.

DOI: 10.1136/fmch-2018-000057

DOI: 10.1080/00207543.2019.1582820

DOI: 10.18639/RABM.2023.9800029

DOI: 10.1016/j.ijpe.2020.107972

DOI: 10.1108/QRJ-08-2022-0116

DOI: 10.1057/s42214-020-00062-w

DOI: 10.1016/j.ejor.2017.04.009

DOI: 10.1016/j.tre.2020.101967

DOI: 10.12688/f1000research.23057.1

DOI: 10.5530/ijper.57.2.74

DOI: 10.4018/978-1-6684-4686-7.ch005

DOI: 10.1108/SCM-09-2020-0439

DOI: 10.1108/IJLM-02-2021-0109

DOI: 10.1108/JEC-05-2020-0104

DOI: 10.1007/978-3-319-69305-7

DOI: 10.1016/j.tre.2020.101922

DOI: 10.1007/s10479-021-04181-2

DOI: 10.1504/IJISM.2020.107780

DOI: 10.1080/00207543.2020.1750727

DOI: 10.1016/j.ijpe.2020.107921

DOI: 10.1017/S095026882100025X

DOI: 10.1016/j.spc.2020.09.019

DOI: 10.1038/s43586-022-00150-6

DOI: 10.1108/IJOEM-11-2021-1680

DOI: 10.1007/s10479-018-2772-8

DOI: 10.1016/j.ijdrr.2022.102983

Moosivand, A., Ghatari, A. R., & Rasekh, H. R. (2019). Supply Chain Challenges in Pharmaceutical Manufacturing Companies: Using Qualitative System Dynamics Methodology. Iranian journal of pharmaceutical research: IJPR, 18(2), 1103.

DOI: 10.1080/00207543.2021.1950937

DOI: 10.1016/j.ejor.2020.08.001

DOI: 10.1177/1609406917733847

DOI: 10.1007/s40622-022-00309-w

DOI: 10.1007/s40171-020-00248-4

DOI: 10.1108/IJPDLM-04-2020-0127

DOI: 10.1007/s10479-020-03685-7

DOI: 10.1016/j.jbusres.2022.01.037

Rehacek, P. (2019). Risk Management as an Instrument of the Effectiveness of Quality Management System. Quality-Access to Success, 20(168).

Roser, M., Ritchie, H., Ortiz-Ospina, E., & Hasell, J. (2021). Coronavirus Pandemic (COVID-19); 2020. Published online at OurWorldInData. org. Avalailbe from: https://ourworldin-data. org/coronavirus [Online Resource].

DOI: 10.1016/j.resconrec.2020.104894

DOI: 10.1080/13675567.2020.1763935

DOI: 10.1002/joom.1161

DOI: 10.5267/j.uscm.2022.2.004

DOI: 10.2105/AJPH.2020.306138

DOI: 10.4018/978-1-7998-9506-0.ch021

Tenny, S., Brannan, J. M., & Brannan, G. D. (2023). Qualitative Study. In StatPearls. StatPearls Publishing

Copyright © 2023, StatPearls Publishing LLC.

DOI: 10.1007/978-3-031-28839-5_59

DOI: 10.1109/TEM.2021.3116068

DOI: 10.1007/978-3-030-46817-0_109

DOI: 10.1111/poms.13525

DOI: 10.1016/j.ejor.2021.07.028

DOI: 10.12731/2658-6649-2022-14-1-436-451

DOI: 10.1007/s12063-021-00179-y

DOI: 10.1016/j.ijpe.2023.108817

DOI: 10.1016/j.cie.2022.108377

DOI: 10.1016/j.tre.2020.101838